Skip to main content
Year archive

ALEMBIC PHARMACEUTICALS LIMITED — 2026 filings

All 82 regulatory filings released by ALEMBIC PHARMACEUTICALS LIMITED (APLLTD) in 2026, sourced directly from the official regulator.

82 Filings
2026 Period
2026 filings (82)
Filing Released Lang
Press Release
Regulatory Filings
2026-05-22 English
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Levothyroxine Sodium Tablets USP.
Regulatory Filings
2026-05-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2026-05-21 English
Please find attached.
Call Transcript
2026-05-21 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2026-05-18 English
Newspaper Publication of Audited Financial Results as on 31st March, 2026.
Earnings Release FY 2026
2026-05-16 English
Copy of Newspaper Publication
Earnings Release FY 2026
2026-05-16 English
Outcome of Board Meeting
Regulatory Filings
2026-05-15 English
Updates
Regulatory Filings
2026-05-15 English
Please find attached.
Regulatory Filings
2026-05-15 English
Analysts/Institutional Investor Meet/Con. Call Updates
Report Publication Announcement
2026-05-15 English
Please find attached.
Report Publication Announcement
2026-05-15 English
Dividend
Interim / Quarterly Report FY 2026
2026-05-15 English
Please find attached.
Earnings Release FY 2026
2026-05-15 English
Press Release
Earnings Release FY 2026
2026-05-15 English
Please find attached.
Investor Presentation
2026-05-15 English
Please fin enclosed herewith Audited Financial Results for the quarter and Financial Year ended 31st March, 2026.
Earnings Release FY 2026
2026-05-15 English
Investor Presentation
Investor Presentation
2026-05-15 English
Outcome of Board Meeting
Regulatory Filings
2026-05-15 English
Outcome of Board Meeting
Interim / Quarterly Report FY 2026
2026-05-15 English
Please find enclosed herewith Outcome of Board Meeting .
Interim / Quarterly Report FY 2026
2026-05-15 English
Resignation of Director/KMP/SMP
Regulatory Filings
2026-05-14 English
Change in Management
Board/Management Information
2026-05-14 English
Resignation of Senior Management Personnel.
Board/Management Information
2026-05-14 English
Please find enclosed.
Regulatory Filings
2026-05-14 English
Updates
Regulatory Filings
2026-05-14 English
Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Darolutamide Tablets, 300 mg.
Regulatory Filings
2026-05-14 English
Press Release
Regulatory Filings
2026-05-14 English
Please find attached herewith the Annual Secretarial Compliance Report for the F.Y. ended 31st March, 2026.
Regulatory Filings
2026-05-09 English
Copy of Newspaper Publication
Regulatory Filings
2026-05-05 English
General Updates
Regulatory Filings
2026-05-04 English
Resignation of Director/KMP/SMP
Regulatory Filings
2026-05-04 English
Resignation of Director/KMP/SMP
Regulatory Filings
2026-05-04 English
Change in Management
Regulatory Filings
2026-05-04 English
Change in Management
Regulatory Filings
2026-05-01 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-04-29 English
Demise
Regulatory Filings
2026-04-27 English
Press Release
Regulatory Filings
2026-04-25 English
General Updates
Regulatory Filings
2026-04-23 English
General Updates
Regulatory Filings
2026-04-22 English
Copy of Newspaper Publication
Regulatory Filings
2026-04-17 English
Press Release
Regulatory Filings
2026-04-16 English
Copy of Newspaper Publication
Regulatory Filings
2026-04-15 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2026-04-08 English
Press Release
Regulatory Filings
2026-04-07 English
Appointment
Regulatory Filings
2026-04-01 English
Cessation
Regulatory Filings
2026-04-01 English
Appointment
Regulatory Filings
2026-04-01 English
Appointment
Regulatory Filings
2026-04-01 English
Shareholders meeting
Regulatory Filings
2026-03-31 English
Change in Management
Regulatory Filings
2026-03-31 English
Press Release
Regulatory Filings
2026-03-27 English
Trading Window
Regulatory Filings
2026-03-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-03-20 English
General Updates
Regulatory Filings
2026-03-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-03-06 English
Press Release
Regulatory Filings
2026-03-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-03-04 English
Copy of Newspaper Publication
Regulatory Filings
2026-03-02 English
Shareholders meeting
Regulatory Filings
2026-02-27 English
Press Release
Regulatory Filings
2026-02-26 English
Press Release
Regulatory Filings
2026-02-24 English
General Updates
Regulatory Filings
2026-02-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-02-11 English
Copy of Newspaper Publication
Regulatory Filings
2026-02-11 English
Copy of Newspaper Publication
Regulatory Filings
2026-02-06 English
Press Release
Regulatory Filings
2026-02-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-02-05 English
Appointment
Regulatory Filings
2026-02-05 English
Investor Presentation
Regulatory Filings
2026-02-05 English
Press Release
Regulatory Filings
2026-02-05 English
Investor Presentation
Regulatory Filings
2026-02-05 English
Outcome of Board Meeting
Regulatory Filings
2026-02-05 English
Outcome of Board Meeting
Regulatory Filings
2026-02-05 English
Copy of Newspaper Publication
Regulatory Filings
2026-02-03 English
Change in Management
Regulatory Filings
2026-01-31 English
Press Release
Regulatory Filings
2026-01-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-01-21 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-01-20 English
Board Meeting — Financial Results
Regulatory Filings
2026-01-20 English
Press Release
Regulatory Filings
2026-01-12 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2026-01-05 English